REQUEST A DEMO
Total
USD $0.00
Search more companies

Li Kang Biomedical Co., Ltd. (Taiwan, China)

Main Activities: Computer and Peripheral Equipment Manufacturing | Communication and Energy Wire and Cable Manufacturing
Full name: Li Kang Biomedical Co., Ltd. Profile Updated: June 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

BAFO Technologies Corp. was founded in April 1985 and received ISO9002 certification from TUV in 1998. It was also CSA certified and C.E. COMPLIANCE certified in 1998 and in 1999 respectively. BAFO was listed in OTC in January 2003. The company is engaged in the manufacture and sale of computing, communication and consumer (3C) product cables and circumscribed computer peripheral products. It offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables and universal serial bus (USB) cables, among others. During the year ended December 31, 2009, 3C product cables and circumscribed computer peripheral products contributed approximately 50% and 47% of the company's total revenue, respectively. The company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.

Headquarters
No.29, Huangong Rd., Yongkang Dist
Tainan City; Tainan City;

Contact Details: Purchase the Li Kang Biomedical Co., Ltd. report to view the information.

Website: http://likangbio.com

Basic Information
Total Employees:
Purchase the Li Kang Biomedical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Li Kang Biomedical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Li Kang Biomedical Co., Ltd. report to view the information.
Incorporation Date:
April 16, 1985
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Assistant Secretary
Ownership Details
Purchase this report to view the information.
18%
Purchase this report to view the information.
1.04%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
醫 鈦 康 股 份 有限公司
100%
Company Performance
Financial values in the chart are available after Li Kang Biomedical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-17.2%
Total operating revenue
-16.82%
Operating profit (EBIT)
-43.61%
EBITDA
-41.53%
Net Profit (Loss) for the Period
-44.37%
Total assets
51.89%
Total equity
39.7%
Operating Profit Margin (ROS)
-7.07%
Net Profit Margin
-6.04%
Return on Equity (ROE)
-6.32%
Quick Ratio
1.12%
Cash Ratio
-0.06%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?